← All decks

General Surgery

Cancer of the Esophagus

Built from Maingot's Abdominal Operations

The first 25 slides of Cancer of the Esophagus
The first 25 slides, exactly as they appear. The full deck has 185 content slides.

What’s inside

13 sections · 185 slides

  1. 01

    Overview

    • Topics covered

    1 slide

  2. 02

    Background and Causes

    Where the disease occurs, who it strikes, and the exposures behind it

    • Cancer of the esophagus in outline
    • Early descriptions and the first resections
    • From resection to reconstruction
    • Global burden of esophageal cancer
    • The Asian esophageal cancer belt
    • High-incidence areas within China
    • The shift from squamous cell cancer to adenocarcinoma
    • Etiologic factors and the two cell types
    • Smoking and alcohol
    • Genetic predisposition in squamous cell cancer
    • Aldehyde dehydrogenase 2 and the flushing response
    • Acetaldehyde handling after a drink
    • Which genotype carries the risk
    • Diet and environment in squamous cell cancer
    • Micronutrient deficiency and changing diet
    • Field cancerization and second cancers
    • Diseases that predispose to esophageal cancer
    • Why adenocarcinoma is rising in the West

    18 slides

  3. 03

    Screening, Surveillance and Prevention

    Finding cancer before it causes symptoms, and trying to stop it forming

    • Abrasive cytology in high-incidence areas
    • Lugol's iodine chromoendoscopy of an early squamous cancer
    • Narrow band imaging of the same lesion
    • Chromoendoscopy with Lugol's iodine
    • The Linxian nutritional intervention trial
    • Arguments against screening the population for Barrett's esophagus
    • Surveillance once Barrett's esophagus is found
    • Dysplasia grade and surveillance interval
    • The metaplasia-dysplasia-cancer sequence
    • Chemoprevention in Barrett's esophagus

    10 slides

  4. 04

    Clinical Presentation

    What patients complain of, and how the two cell types differ at the bedside

    • Symptoms of advanced esophageal cancer
    • Odynophagia, hoarseness and the clues they give
    • Two different patients behind the two cell types
    • Squamous cell cancer and adenocarcinoma compared

    4 slides

  5. 05

    Tumour Staging

    How deep, how many nodes, how far - and how the categories are grouped

    • Purpose of accurate staging
    • T categories for the primary tumour
    • Depth of invasion behind the T categories
    • Reading the T categories
    • N and M categories
    • Counting nodes for the N category
    • What changed in the revised TNM system
    • Histologic grade categories
    • Grade of differentiation
    • Stage groupings for squamous cell carcinoma
    • Stage groupings for adenocarcinoma
    • Why the two cell types are grouped differently
    • Levels of the esophagus used in staging
    • Levels of the esophagus
    • Lymph node stations of the esophagus
    • American Joint Committee on Cancer node stations
    • Staging tumours at the gastroesophageal junction
    • Siewert classification of junctional adenocarcinoma
    • Type I adenocarcinoma arising from Barrett's esophagus
    • Type II cardia cancer specimen and barium study
    • Siewert types I, II and III
    • Divisions of T1 tumours by the Japan Esophageal Society
    • Subdividing T1a and T1b

    23 slides

  6. 06

    Methods of Staging

    The investigations that answer depth, nodes and distant spread

    • What each staging test answers best
    • Barium contrast studies
    • Barium study of a stenotic tumour
    • Bronchoscopy
    • Computed tomography for distant disease
    • Computed tomography for local and nodal disease
    • Combined PET and CT of a hilar node
    • Endoscopic ultrasound and the wall layers
    • Endoscopic ultrasound of an early mucosal tumour
    • Accuracy and reach of endoscopic ultrasound
    • The non-traversable stricture
    • Percutaneous ultrasound of neck nodes
    • FDG-PET for the primary tumour
    • FDG-PET for regional nodes
    • Does PET change the operative decision
    • Thoracoscopic and laparoscopic staging

    16 slides

  7. 07

    Treatment of Early Cancer

    Removing the disease through the endoscope, and when that is not enough

    • Depth and nodal risk in early squamous cell cancer
    • 0%
    • Selecting lesions for endoscopic resection
    • Indications for endoscopic resection of esophageal cancer
    • Cap-assisted endoscopic mucosal resection
    • Results of endoscopic mucosal resection
    • Endoscopic submucosal dissection
    • Complications of endoscopic resection
    • The case against watching high-grade dysplasia
    • Invasive cancer hidden inside high-grade dysplasia
    • Localized resection in Barrett's cancer
    • Circumferential resection and whole-segment ablation
    • Photodynamic therapy
    • Radiofrequency ablation devices
    • Radiofrequency ablation in non-dysplastic Barrett's esophagus
    • Randomized trial of ablation for dysplastic Barrett's esophagus
    • Vagal-sparing and limited resection
    • Choosing between the three options

    18 slides

  8. 08

    Surgical Resection for Advanced Cancer

    Choosing the patient, the approach, the margins and the node clearance

    • Patient selection for esophagectomy
    • Predictors of morbidity and mortality
    • Risk scoring before esophagectomy
    • Pharyngolaryngoesophagectomy for cervical cancer
    • Reconstruction after cervical resection
    • Sacrificing the larynx, and the alternative
    • Three-phase (McKeown) esophagectomy
    • Phases of the Lewis-Tanner operation
    • The Lewis-Tanner operation
    • The left thoracotomy approach
    • The transhiatal approach
    • Abdominal esophagus and cardia tumours
    • Transthoracic and transhiatal resection compared
    • The argument over access
    • The randomized trial of transhiatal versus transthoracic resection
    • Choosing an approach by tumour site
    • Minimally invasive esophagectomy
    • Evidence for minimally invasive esophagectomy
    • Why the benefit is hard to prove
    • R0 resection and the axial margin
    • How long a proximal margin
    • Limits of margin status
    • Lateral margin and en bloc resection
    • Extent of lymphadenectomy
    • Standard, extended and three-field clearance
    • Standard and extended mediastinal lymphadenectomy
    • Total mediastinal lymphadenectomy
    • Nodal spread in squamous cell cancer
    • Infracarinal mediastinal dissection
    • Superior mediastinal dissection
    • Right recurrent laryngeal nerve node dissection
    • Abdominal lymphadenectomy at the celiac trifurcation
    • Cervical lymphadenectomy
    • Morbidity of three-field lymphadenectomy
    • Refining the indications
    • Criticism of three-field dissection
    • Nodal spread in Barrett's adenocarcinoma
    • En bloc resection results
    • Surgery for cardia cancer
    • The JCOG 9502 trial
    • Number of nodes removed and survival
    • ~10

    42 slides

  9. 09

    Reconstruction After Esophagectomy

    Which organ replaces the esophagus, by which route, and how it functions

    • The gastric conduit
    • Gastric conduit prepared for transposition to the neck
    • Drawbacks of the gastric conduit
    • Gastric emptying after esophagectomy
    • Colonic interposition
    • Jejunal reconstruction
    • Route of the conduit
    • Recurrent tumour and the reconstruction route

    8 slides

  10. 10

    Perioperative Care and Complications

    The complications that determine whether the operation succeeds

    • Cardiac events and atrial arrhythmia
    • Pulmonary complications
    • Reducing pulmonary complications
    • Anastomotic leak
    • Stapled versus hand-sewn anastomosis
    • Technical complications drive outcome
    • Improvement in leak outcomes over time

    7 slides

  11. 11

    Multimodal Treatment

    Radiotherapy, chemotherapy and chemoradiation around the operation

    • Neoadjuvant radiotherapy
    • Adjuvant radiotherapy
    • Randomized trials of neoadjuvant chemotherapy versus surgery
    • The Intergroup INT 0113 trial
    • The MRC OE02 trial
    • JCOG 9907 and the MAGIC trial
    • Meta-analyses of preoperative chemotherapy
    • Adjuvant chemotherapy
    • Randomized trials of neoadjuvant chemoradiation, first group
    • Randomized trials of neoadjuvant chemoradiation, remaining trials
    • Neoadjuvant chemoradiation trials
    • Meta-analysis of neoadjuvant chemoradiation
    • Definitive chemoradiation without surgery
    • The FFCD 9102 trial
    • The German chemoradiation trial
    • Why it is premature to abandon surgery
    • Local control and residual disease
    • Predicting response to treatment
    • PET/CT before and after chemoradiation therapy
    • The MUNICON trial
    • Results of the MUNICON trial
    • The MUNICON-2 trial
    • Newer drugs and radiation techniques

    23 slides

  12. 12

    Endoscopic Palliation

    Restoring swallowing when cure is no longer possible

    • Self-expanding metallic stents
    • Self-expanding metallic stent in situ
    • Metallic versus plastic prostheses
    • Problems with metallic stents
    • Restoring patency and choosing a stent
    • Stents near the upper esophageal sphincter

    6 slides

  13. 13

    Summary and Future Directions

    Where treatment stands, and what still has to be solved

    • Where treatment stands
    • Remaining problems
    • Points to carry away
    • References
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • Maingot's Abdominal Operations, 12th Edition

    9 slides